Company News, Financial News

Q2 Sales Rise at J&J

Neutrogena, Aveeno and Listerine are fueling business.

Johnson & Johnson posted a 9.1% increase in sales of $19.5 billion for the second quarter of 2014.  Positive contributors to operational results were sales of Neutrogena and Aveeno skin care products; baby care products; and international sales of Listerine mouthwash and feminine protection products, according to the company. Skin care sales rose 6.6% to $968 million, while baby care increased 3.6% to $607 million and oral care inched up 1.7% to $413 million.   Operational results increased...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters